statistically significant p

Related by string. * Statistically . STATISTICALLY : statistically significant improvement . demonstrated statistically significant . statistically significant reduction / signifi cant . sig nificant . Signifi cant : statistically significant correlation . statistically significant differences . Significant Items / PS . PD : & P . Ten Per Cent * statistically significant p = *

Related by context. Frequent words. (Click for all words.) 73 placebo p 71 placebo p = 67 P = .# 66 p = 65 statistically significant 64 p = #.# [002] 64 log# 63 p = #.# [004] 61 confidence interval CI 61 confidence interval #.#-#.# 61 nonsignificant 60 serum phosphorus 60 statistically significant reduction 60 % CI #.#-#.# [006] 60 mcg kg 59 plus methotrexate 59 serum concentrations 59 annualized relapse 59 pg mL 59 Secondary endpoints included 59 IU mL 59 evaluable 59 laboratory abnormalities 58 nmol L 58 IPSS 58 unfractionated heparin 58 HbA1c levels 58 mg d 58 % CI #.#-#.# [002] 57 placebo 57 prespecified 57 febrile neutropenia 57 copies mL 57 Secondary endpoints include 57 statistically significant improvement 57 LVEF 57 mg dose 57 noninferiority 57 sustained virologic response 56 r = 56 leukopenia 56 mRNA expression 56 Pharmacokinetic 56 fasting insulin 56 demonstrated statistically significant 56 HbA1c 56 median PFS 56 DAS# [002] 56 adefovir 56 fasting plasma glucose 56 tiotropium 56 treatment emergent adverse 56 peginterferon alfa 2b 56 Secondary endpoints 55 composite endpoint 55 mmol L 55 HCV RNA 55 discontinuations due 55 CI = 55 creatinine clearance 55 eGFR 55 mg dL 55 nonresponders 55 undetectable viral load 55 alkaline phosphatase 55 Tolerability 55 abciximab 54 bosentan 54 mg BID 54 g dL 54 inflammatory lesions 54 df = 54 54 ziprasidone 54 FOLFIRI 54 hypokalemia 54 μg 54 statistically significant differences 54 histologic 54 mg doses 54 thromboembolism 54 tamsulosin 54 quetiapine 54 peginterferon alfa 2a 54 copies ml 54 n = 54 hypercalcemia 54 vertebral fracture 54 nasopharyngitis 54 mitoxantrone 54 viral load 53 infarct size 53 glomerular filtration rate 53 plasma concentrations 53 seliciclib 53 decitabine 53 Postoperative 53 thromboembolic events 53 fluorouracil 53 postoperatively 53 left ventricular dysfunction

Back to home page